Lakefront Biotherapeutics Stock Price, News & Analysis
Company Description
Lakefront Biotherapeutics (OTC Link: GLPGF) is a publicly traded company.
GLPGF stock has gained 2.1% over the past year. Shares last traded at $28.08.
This page provides a comprehensive overview of GLPGF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Lakefront Biotherapeutics (GLPGF) stock last traded at $28.08. Over the past 12 months, the stock has gained 2.1%.
Latest News
SEC Filings
Lakefront Biotherapeutics has filed 10 recent SEC filings, including 10 Form 6-K. The most recent filing was submitted on June 9, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all GLPGF SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Lakefront Biotherapeutics (GLPGF) currently stands at 181.0 thousand shares, down 30.8% from the previous reporting period, representing 0.4% of the float. Over the past 12 months, short interest has decreased by 22.1%. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Lakefront Biotherapeutics (GLPGF) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The ratio has shown significant volatility over the period, ranging from 3.3 to 1000.0 days.